Raymond James Financial Inc. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 410,137 shares of the semiconductor company's stock, valued at approximately $199,065,000. Raymond James Financial Inc. owned about 0.27% of Synopsys at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Kieckhefer Group LLC bought a new stake in Synopsys in the 4th quarter valued at $27,000. Whipplewood Advisors LLC acquired a new stake in shares of Synopsys during the 4th quarter worth about $33,000. Sierra Ocean LLC acquired a new stake in shares of Synopsys during the 4th quarter worth about $39,000. Newbridge Financial Services Group Inc. acquired a new position in Synopsys in the 4th quarter valued at about $51,000. Finally, Versant Capital Management Inc raised its holdings in Synopsys by 109.3% in the 4th quarter. Versant Capital Management Inc now owns 113 shares of the semiconductor company's stock valued at $55,000 after acquiring an additional 59 shares during the period. Institutional investors own 85.47% of the company's stock.
Insider Transactions at Synopsys
In other news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. The trade was a 13.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CRO Richard S. Mahoney sold 20,838 shares of the business's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares of the company's stock, valued at $738,774.60. This trade represents a 93.45 % decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
Synopsys Stock Performance
Shares of Synopsys stock traded up $5.15 during trading on Friday, reaching $450.88. 1,119,173 shares of the company's stock were exchanged, compared to its average volume of 1,189,363. Synopsys, Inc. has a 1-year low of $429.77 and a 1-year high of $624.80. The company has a market cap of $69.72 billion, a P/E ratio of 31.05, a PEG ratio of 3.23 and a beta of 1.16. The firm's 50-day moving average price is $501.21 and its 200 day moving average price is $512.03.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the company. Redburn Atlantic began coverage on Synopsys in a report on Monday, January 13th. They set a "buy" rating and a $600.00 price objective for the company. Morgan Stanley reduced their price target on Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research note on Monday, February 24th. Needham & Company LLC reiterated a "buy" rating and set a $650.00 price objective on shares of Synopsys in a research report on Thursday, February 27th. Wells Fargo & Company reduced their target price on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a research report on Thursday, February 27th. Finally, Rosenblatt Securities reaffirmed a "buy" rating and set a $660.00 price target on shares of Synopsys in a research report on Tuesday, February 25th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $638.58.
Check Out Our Latest Stock Report on SNPS
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.